<?xml version="1.0" encoding="UTF-8"?>
<ref id="B2">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Barros-Tizón</surname>
    <given-names>J. C.</given-names>
   </name>
   <name>
    <surname>Torres</surname>
    <given-names>M. L.</given-names>
   </name>
   <name>
    <surname>Blanco</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Martínez</surname>
    <given-names>M. T.</given-names>
   </name>
  </person-group> (
  <year>2012</year>). 
  <article-title>Investigators of the rEXA study groupReduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy</article-title>. 
  <source>Ther. Adv. Respir.</source>
  <volume>6</volume>, 
  <fpage>67</fpage>–
  <lpage>78</lpage>. 
  <pub-id pub-id-type="doi">10.1177/1753465812438387</pub-id>
 </mixed-citation>
</ref>
